Orion Healthcare Equity Partners
3
9M
2
0.20
0.33
1
- Stages of investment
- Areas of investment
Summary
Orion Healthcare Equity Partners is the famous VC, which was founded in 2007. The venture was found in North America in United States. The main department of described VC is located in the Boston.
The standard case for the fund is to invest in rounds with 5 partakers. The meaningful sponsors for the fund in investment in the same round are Sanofi-Genzyme BioVentures, Roche Venture Fund, Pfizer Venture Investments. In the next rounds fund is usually obtained by Sanofi-Genzyme BioVentures, Roche Venture Fund, Partners Innovation Fund.
This organization was formed by Mark Carthy.
The high activity for fund was in 2016. The higher amount of exits for fund were in 2017. The common things for fund are deals in the range of 1 - 5 millions dollars. The fund is generally included in less than 2 deals every year.
For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the various public portfolio startups of the fund, we may underline AnTolRx, Lysosomal Therapeutics Moreover, a startup needs to be at the age of 1 and less years to get the investment from the fund. The fund has no exact preference in some founders of portfolio startups. Among the most successful fund investment fields, there are Therapeutics, Biotechnology.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 0.20
- Follow on index
- 0.33
- Investments by industry
- Biotechnology (3)
- Health Care (3)
- Therapeutics (2)
- Investments by region
-
- United States (3)
- Peak activity year
- 2016
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Group Appearance index
- 1.00
- Avg. company exit year
- 6
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Lysosomal Therapeutics | 03 Feb 2015 | Biotechnology, Health Care, Therapeutics | Early Stage Venture | 20M | United States, Massachusetts, Cambridge |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.